These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 12965912)
1. Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment. Pereira-Chioccola VL; Fragata-Filho AA; Levy AM; Rodrigues MM; Schenkman S Clin Diagn Lab Immunol; 2003 Sep; 10(5):826-30. PubMed ID: 12965912 [TBL] [Abstract][Full Text] [Related]
2. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections. Leguizamón MS; Campetella O; Russomando G; Almiron M; Guillen I; Ganzález Cappa SM; Frasch AC J Infect Dis; 1994 Dec; 170(6):1570-4. PubMed ID: 7995998 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic Applicability of Neutralizing Antibodies to Trypanosoma cruzi Trans-sialidase. Leguizamón MS Methods Mol Biol; 2019; 1955():239-246. PubMed ID: 30868532 [TBL] [Abstract][Full Text] [Related]
6. trans-sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas' disease. Buchovsky AS; Campetella O; Russomando G; Franco L; Oddone R; Candia N; Luquetti A; Gonzalez Cappa SM; Leguizamon MS Clin Diagn Lab Immunol; 2001 Jan; 8(1):187-9. PubMed ID: 11139217 [TBL] [Abstract][Full Text] [Related]
7. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease. Solana ME; Katzin AM; Umezawa ES; Miatello CS J Clin Microbiol; 1995 Jun; 33(6):1456-60. PubMed ID: 7650167 [TBL] [Abstract][Full Text] [Related]
8. Long-lasting antibodies detected by a trans-sialidase inhibition assay of sera from parasite-free, serologically cured chagasic patients. Leguizamón MS; Russomando G; Luquetti A; Rassi A; Almirón M; González-Cappa SM; Frasch AC; Campetella O J Infect Dis; 1997 May; 175(5):1272-5. PubMed ID: 9129103 [TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease. Chuenkova M; Pereira ME J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448 [TBL] [Abstract][Full Text] [Related]
10. Detection of antibodies in sera from Chagas' disease patients using a Trypanosoma cruzi immunodominant recombinant antigen. Paranhos-Bacalla GS; Santos MR; Cotrim PC; Rassi A; Jolivet M; Camargo ME; Da Silveira JF Parasite Immunol; 1994 Mar; 16(3):165-9. PubMed ID: 8208589 [TBL] [Abstract][Full Text] [Related]
12. Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins. Krautz GM; Peterson JD; Godsel LM; Krettli AU; Engman DM Am J Trop Med Hyg; 1998 Feb; 58(2):137-43. PubMed ID: 9502594 [TBL] [Abstract][Full Text] [Related]
13. IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis. Chiller TM; Samudio MA; Zoulek G Am J Trop Med Hyg; 1990 Dec; 43(6):650-6. PubMed ID: 2125177 [TBL] [Abstract][Full Text] [Related]
14. Use of an enzyme-linked immunosorbent assay that utilizes the Tc13Tul antigen of Trypanosoma cruzi to monitor patients after treatment with benznidazole. Santamaría AL; De Rissio AM; Riarte A; Garavaglia PA; Bruballa AC; Rodríguez MA; Irazu LE; Ruiz AM; García GA Diagn Microbiol Infect Dis; 2013 Jun; 76(2):197-205. PubMed ID: 23537784 [TBL] [Abstract][Full Text] [Related]
15. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease. Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103 [TBL] [Abstract][Full Text] [Related]
16. Multiepitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in patients with treated or untreated Chagas' disease. Houghton RL; Benson DR; Reynolds L; McNeill P; Sleath P; Lodes M; Skeiky YA; Badaro R; Krettli AU; Reed SG J Infect Dis; 2000 Jan; 181(1):325-30. PubMed ID: 10608782 [TBL] [Abstract][Full Text] [Related]
17. [Reactivity of GST-SAPA antigen of Trypanosoma cruzi against sera from patients with Chagas disease and leishmaniasis]. Gil J; Cimino R; López Quiroga I; Cajal S; Acosta N; Juarez M; Zacca R; Orellana V; Krolewiecki A; Diosque P; Nasser J Medicina (B Aires); 2011; 71(2):113-9. PubMed ID: 21550926 [TBL] [Abstract][Full Text] [Related]
18. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease. Matsumoto TK; Hoshino-Shimizu S; Nakamura PM; Andrade HF; Umezawa ES J Clin Microbiol; 1993 Jun; 31(6):1486-92. PubMed ID: 8314991 [TBL] [Abstract][Full Text] [Related]
19. The repetitive domain of Trypanosoma cruzi trans-sialidase enhances the immune response against the catalytic domain. Buscaglia CA; Campetella O; Leguizamón MS; Frasch AC J Infect Dis; 1998 Feb; 177(2):431-6. PubMed ID: 9466532 [TBL] [Abstract][Full Text] [Related]
20. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease. Laucella SA; de Titto EH; Segura EL Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]